Fig. 3
From: HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer
Kaplan-Meier survival curves illustrating the significance of HBXIP expression in ovarian cancer. a OS rates of patients with high (n = 72) and low (n = 48) HBXIP expression. b–d High HBXIP expression was strongly associated with poor OS in G1 (n = 19), G2 (n = 16) and G3 (n = 37). e–f High HBXIP expression was strongly associated with poor OS in patients without lymph node metastasis (n = 30) and with lymph node metastasis (n = 42). g–h High HBXIP expression was strongly associated with poor OS in early-stage (n = 16) and late-stage (n = 56). (a: Log-rank =22.665, P = 0.000; b: Log-rank =4.345, P = 0.037; c: Log-rank = 5.038, P = 0.025; d: Log-rank = 10.535, P = 0.001; e: Log-rank =8.979, P = 0.003; f: Log-rank = 9.782, P = 0.002; g: Log-rank = 5.459, P = 0.019; h: Log-rank = 9.595, P = 0.002.)